Multitask neural screening identifies four experimentally active antitrypanosomal hits
Source check: Source checked. Not independent scientific confirmation.
Finding: Multitask neural activity models guided identification of four experimentally active compounds. This record represents the antitrypanosomal assay result, not four unprecedented chemical entities. LC-15 also appears in a later Leishmania study, which is a separate measured result.
Technology: Multitask feedforward and message-passing neural networks
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Multitask neural models learn compound activity across related tasks and prioritize experimental candidates.
- Test and result
- The primary abstract reports four experimental hits. Official supplementary computational tables compare multitask classification/regression with single-task baselines.
- Limitation / still unknown
- Main article Methods were inaccessible; operational assays were not reviewed. No mechanism, animal or clinical efficacy, absolute chemical novelty, or independent replication is claimed. Publisher online September 13 differs from the August issue date in indexing metadata.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.tandfonline.com/doi/abs/10.4155/fmc-2023-0074 · https://doi.org/10.25402/FMC.24131556.v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary abstract/front, fresh bibliographic status metadata and official supplementary computational tables. Previously reviewed exact LC-15 identity comparison reused without reopening structures or procedures..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.